Can the novel aldosterone inhibiting drug balcinrenone reduce hyperkalaemia and worsening renal function compared to steroidal mineralocorticoid receptor antagonists in heart failure?
Saved in:
| Title: | Can the novel aldosterone inhibiting drug balcinrenone reduce hyperkalaemia and worsening renal function compared to steroidal mineralocorticoid receptor antagonists in heart failure? |
|---|---|
| Authors: | Beldhuis, Iris E.1 (AUTHOR), Heerspink, Hiddo J.L.2 (AUTHOR), Voors, Adriaan A.1 (AUTHOR) a.a.voors@umcg.nl |
| Source: | European Journal of Heart Failure. Feb2025, Vol. 27 Issue 2, p232-235. 4p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 13889842 |
|---|---|
| DOI: | 10.1002/ejhf.3387 |
